Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 25, 2024 07:00 ET
American Airlines Reports First-Quarter 2024 Financial Results
American Airlines Group Inc. (NASDAQ: AAL) today reported its first-quarter 2024 financial results, including: Record first-quarter revenue of approximately $12.6 billion.First-quarter net loss of $312 million, or ($0.48) per diluted share....
Apr 25, 2024 07:00 ET
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first...
Apr 25, 2024 07:00 ET
Connectone Bancorp, Inc. Reports First Quarter 2024 Results; Declares Preferred and Increased Common Dividends
ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $15.7 million for the first quarter of 2024 compared with $17.8...
Apr 25, 2024 07:00 ET
DTE Energy reports first quarter earnings and accomplishments
DTE Energy (NYSE:DTE) today reported that it invested over $1 billion into improving its electric and natural gas infrastructure in the first quarter of 2024 and is on track to invest over $4 billion this year on a mission to continue improving...
Apr 25, 2024 07:00 ET
Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension
Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today provided an update on its two FDA-approved products. Phase IV study of Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% Eyenovia...
Apr 25, 2024 07:00 ET
Gov. Holcomb announces Amazon Web Services plans to invest $11B to create a new data center campus in Northern Indiana
Governor Eric J. Holcomb, chairman of the Indiana Economic Development Corporation, today announced that Amazon Web Services (AWS), an Amazon.com. Inc. company (NASDAQ: AMZN), plans to invest $11 billion to build a data center campus in north...
Apr 25, 2024 07:00 ET
IBN Coverage Initiated for Nutriband Inc.
via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to...
Apr 25, 2024 07:00 ET
Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), will report first quarter 2024 financial results on May 2, 2024, and...
Apr 25, 2024 07:00 ET
Nasdaq Reports First Quarter 2024 Results; Strong Execution Delivers Double-Digit Solutions Revenue Growth
Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2024. First quarter 2024 net revenues1 were $1.1 billion, an increase of 22% over the first quarter of 2023, up 6% organically2 or 7% on a pro forma3 basis,...
Apr 25, 2024 07:00 ET
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced corporate updates detailing its commercial plans and expectations for XHANCE® (fluticasone...
Apr 25, 2024 07:00 ET
OTC Markets Group Welcomes Roth CH Acquisition Co. to OTCQX
OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Roth CH Acquisition Co. (OTCQX: USCTF), a special purpose acquisition company, has qualified to trade on the...
Apr 25, 2024 07:00 ET
Plug Signs Additional BEDP Contracts for a Total of 4.5GW of Electrolyzers Across Europe and the United States
Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has signed two additional contracts to deliver Basic Engineering and Design Packages (BEDP) for projects in Europe and the U.S. with...
Apr 25, 2024 07:00 ET
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance,...
Apr 25, 2024 07:00 ET
PyroGenesis Announces Receipt of Two Separate Milestone Payments Totaling $970,000
PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions...
Apr 25, 2024 07:00 ET
Sandy Spring Bancorp Declares Quarterly Dividend
Sandy Spring Bancorp, Inc., (Nasdaq- SASR), the parent company of Sandy Spring Bank, announced that the board of directors declared a quarterly common stock dividend of $0.34 per share payable on May 15, 2024 to shareholders of record on May 8,...
Apr 25, 2024 07:00 ET
Stericycle, Inc. Reports Results For The First Quarter 2024
Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were $664.9 million, a decrease of 2.8% compared to $684.3 million in the first quarter of 2023. Income from...
Apr 25, 2024 07:00 ET
Sweetwater Brewing Unveils Modern Rebrand
SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY), today announced a design refresh to make the Sweetwater brand more...
Apr 25, 2024 07:00 ET
Tecnoglass Sets Date for First Quarter 2024 Results
Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial...
Apr 25, 2024 07:00 ET
Wolf Popper LLP Continues its Investigation on Behalf of Investors in Harmony Biosciences Holdings, Inc.
Wolf Popper LLP is continuing to investigate potential securities fraud claims on behalf of purchasers of Harmony Biosciences Holdings, Inc. (“Harmony”) common stock (NASDAQ: HRMY). Harmony is a commercial and clinical stage drug company that...
Apr 25, 2024 07:00 ET
Wolf Popper LLP Continues its Investigation on Behalf of Investors in Temenos AG
Wolf Popper LLP is continuing to investigate potential securities fraud claims on behalf of purchasers of Temenos AG (“Temenos” or the “Company”) American Depositary Shares (OTC: TMSNY). Before the market opened on February 15, 2024, Hindenburg...